Covalent Fluorescent Probes for Cancer Cell Detection
Covalent Fluorescent Probes for Cancer Cell Detection
批准号:
8065802
负责人:
NATHANAEL Schiander GRAY
金额:
$14.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2013-08-31
关键词:
Affinity ChromatographyBODIPYBenzodiazepinesBiological MarkersBiotinBostonCancer BiologyCancer CenterCancer cell lineCell physiologyCellsChromosomal RearrangementCollaborationsCysteineDana-Farber Cancer InstituteDetectionDevelopmentEpidermal Growth Factor ReceptorEquilibriumEventFamilyFibroblast Growth Factor ReceptorsFluorescenceFluorescent ProbesGene AmplificationGenesGoalsGray unit of radiation doseImageryInstitutionLabelLibrariesMalignant NeoplasmsMass Spectrum AnalysisMentorsMethodsMicroscopyPersonsPhosphotransferasesPoint MutationPopulationProtein KinaseRelative (related person)Research PersonnelScreening procedureSiteStaining methodStainsTrainingYangabstractingbasebiological systemscancer cellcareercareer developmentcellular engineeringcovalent bondfluorescence imagingimaging probeinhibitor/antagonistkinase inhibitormedical schoolsmembernovelscaffoldsensorskillssmall moleculetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract: Fluorescence imaging is a powerful tool that permits visualization of specific cell states within a population; however, existing methods for fluorescence labeling are not experimentally accessible for many biological systems. Furthermore, fluorescent small-molecule sensors of cell state may provide a valuable alternative with significant benefits relative to existing methods for fluorescence imaging. The overall goal of
this project is to create fluorescent small molecule ATP-site directed probes that can selectively label particular kinases and serve as imaging probes of normal versus pathological cell state. Protein kinases are in many ways ideal targets for the development of selective small molecule imaging probes for use in cancer biology.
This is because protein kinases are involved in most cellular processes and changes in their localization, accessibility, and abundance are associated with changes in cellular state. Protein kinases have been used as biomarkers in cancer biology because the loss of endogenous kinase regulatory mechanisms by point mutations, gene deletions, gene amplifications, and chromosomal rearrangements has been well-established
as crucial events in many cancers. The specific aims of this project are to: 1) Synthesize fluorescently-tagged kinase inhibitors capable of forming covalent bonds with ATP-site cysteine residues; 2) Use microscopy-based screening ofthe compounds prepared in Aim 1 to identify compounds that are selective-probes of normal and pathological cellular states and 3) Identify the intracellular target(s) of active compounds identified in Aim 2.
This proposed is the extension of an ongoing collaboration between Drs. Nathanael Gray (Dana Farber Cancer Institute), Priscilla Yang (Harvard Medical School) and Wei Zhang (UMass Boston). All three are also members of the Dana Farber/Harvard Cancer Center. One of the strong points of this proposal is that each Co-Pl is responsible for one of the three Specific Aims allowing the project to be benefited by the balanced skills and expertise that each person and their subsequent institution brings to the partnership. Because all three investigators are eariy in their careers, Drs. Gray, Yang and Zhang will benefit from career development activities and mentors who are intemal and extemal. Additionally, the Training Core will significantiy contribute to this project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting CDK7 in CCNE1-amplified Ovarian Cancer
-
批准号:10367792
-
项目类别:
-
资助金额:$72.71万
-
财政年份:2022
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Targeting CDK7 in CCNE1-amplified Ovarian Cancer
-
批准号:10576332
-
项目类别:
-
资助金额:$68.47万
-
财政年份:2022
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Small molecule-induced degradation of dengue proteins as an antiviral strategy
-
批准号:10472071
-
项目类别:
-
资助金额:$81.09万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Small molecule-induced degradation of dengue proteins as an antiviral strategy
-
批准号:10052821
-
项目类别:
-
资助金额:$82.98万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Validating the Flavivirus Envelope Protein as an Antiviral Target
-
批准号:10338189
-
项目类别:
-
资助金额:$96.12万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Validating the Flavivirus Envelope Protein as an Antiviral Target
-
批准号:10578759
-
项目类别:
-
资助金额:$96.12万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Validating the Flavivirus Envelope Protein as an Antiviral Target
-
批准号:10413666
-
项目类别:
-
资助金额:$85.19万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Small molecule-induced degradation of dengue proteins as an antiviral strategy
-
批准号:10661608
-
项目类别:
-
资助金额:$83.59万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Small molecule-induced degradation of dengue proteins as an antiviral strategy
-
批准号:10429876
-
项目类别:
-
资助金额:$81.11万
-
财政年份:2020
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer
-
批准号:10174856
-
项目类别:
-
资助金额:$65.64万
-
财政年份:2017
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors
-
批准号:8942703
-
项目类别:
-
资助金额:$54.09万
-
财政年份:2015
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors
-
批准号:9262888
-
项目类别:
-
资助金额:$54.09万
-
财政年份:2015
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Development and Application of Selective Covalent Cdk7 Inhibitors
-
批准号:8701553
-
项目类别:
-
资助金额:$50.6万
-
财政年份:2014
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Development and Application of Selective Covalent Cdk7 Inhibitors
-
批准号:9033083
-
项目类别:
-
资助金额:$50.12万
-
财政年份:2014
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Development and Application of Selective Covalent Cdk7 Inhibitors
-
批准号:8827302
-
项目类别:
-
资助金额:$50.36万
-
财政年份:2014
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL
-
批准号:8924770
-
项目类别:
-
资助金额:$70.8万
-
财政年份:2013
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL
-
批准号:9330826
-
项目类别:
-
资助金额:$69.94万
-
财政年份:2013
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Developing Selective EphA2 Inhibitors for the treatment of Cancer
-
批准号:8429912
-
项目类别:
-
资助金额:$52.45万
-
财政年份:2013
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Developing Selective EphA2 Inhibitors for the treatment of Cancer
-
批准号:8643194
-
项目类别:
-
资助金额:$50.88万
-
财政年份:2013
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
Chemical Tools for the Study of Dengue Virus Entry
-
批准号:8653822
-
项目类别:
-
资助金额:$42.16万
-
财政年份:2013
-
负责人:NATHANAEL Schiander GRAY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
新型光动力BODIPY衍生物靶向FDX1诱导铜死亡抑制骨肉瘤的机制研究
-
批准号:2026JJ50597
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李劲松
-
依托单位:
稠环连接的扩展卟啉BODIPY的合成及光物理性能研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
Meso位C=N修饰的BODIPY类AIE光敏剂构筑及Aβ成像和光氧化治疗一体化研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:史文静
-
依托单位:
基于BODIPY的低氧响应纳米诊疗系统用于三阴性乳腺癌精准免疫治疗研究
-
批准号:2024Y9242
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:林雨翔
-
依托单位:
近红外光响应多重螺烯BODIPY类似物的构筑及圆偏振发光性能研究
-
批准号:22301188
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:琚洋洋
-
依托单位:
基于X-BODIPY可控自组装基元开发响应性抗结直肠癌超分子纳米诊疗平台
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:苏美慧
-
依托单位:
肿瘤微环境-气体释放激活Aza-BODIPY染料用于二次放大多模态肿瘤诊疗一体化研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:徐云剑
-
依托单位:
离子液体导向构建卟啉−BODIPY金属有机框架材料及其光捕获性能研究
-
批准号:--
-
项目类别:--
-
资助金额:54万元
-
批准年份:2022
-
负责人:秦建华
-
依托单位:
通过激发态动力学研究精准制备高性能Aza-BODIPY类NIR-II荧光造影剂
-
批准号:62175201
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:胡文博
-
依托单位:
基于稠环BODIPY的近红外纯有机室温磷光材料的合成与性能研究
-
批准号:22108078
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘秀军
-
依托单位: